Regeneron Pharmaceuticals (REGN) Deferred Revenue & History | Stock Alarm

Demo Sign up Log In

Regeneron Pharmaceuticals · Deferred Revenue

REGN Deferred Revenue

Latest reported$553.00Mperiod endingDec 31, 2025

REGN FY Deferred Revenue ($0.00 → $553.00M)

Annual deferred revenue

High-resolution chart · PNG

REGN deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Deferred Revenue — Annual fiscal periods (USD)
Period ending	Deferred Revenue (USD)
Dec 31, 2025	553,000,000
Dec 31, 2024	627,700,000
Dec 31, 2023	458,900,000
Dec 31, 2022	477,900,000
Dec 31, 2021	442,000,000
Dec 31, 2020	577,700,000
Dec 31, 2019	591,700,000
Dec 31, 2018	452,500,000
Dec 31, 2017	320,138,000
Dec 31, 2016	231,664,000
Dec 31, 2015	153,487,000
Dec 31, 2014	74,025,000
Dec 31, 2013	47,000,000
Dec 31, 2012	50,831,000
Dec 31, 2011	300,250,000
Dec 31, 2010	54,723,000
Dec 31, 2009	44,544,000
Dec 31, 2008	209,925,000
Dec 31, 2007	44,432,000
Dec 31, 2006	23,543,000
Dec 31, 2005	17,020,000
Dec 31, 2004	15,267,000
Dec 31, 2003	40,173,000
Dec 31, 2002	9,659,000
Dec 31, 2001	6,766,000
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.